Welsh NHS Confederation Conference 2019
Total Page:16
File Type:pdf, Size:1020Kb
ABPI Cymru Wales Special Bulletin Edition WINTER 2019 Edition 23 The NHS and pharmaceutical industry working together to transform patient care – Welsh NHS Confederation Conference 2019 Wales should aspire to nothing less than a health and care system that delivers the best patient outcomes. We believe that strong partnerships between NHS Wales, patient organisations, academia and the pharmaceutical industry is the best way to improve outcomes for patients now and in the future. Together we can: ABPI President Erik Nordkamp has made collaboration the focus of his presidency Deliver ambitious, scalable projects that improve patient outcomes, create efficiencies During an interview setting the focus services and deliver the efficiency within the NHS and reduce for his Presidency in 2018, Erik said: and productivity so urgently needed. health inequalities for people “Today, we are able to prevent, By being involved at the earliest across Wales manage and even cure diseases in possible stage in strategic planning, Create an innovation-ready ways we couldn’t have imagined we can work with the NHS and NHS that can embrace new in years past. Healthcare is Governments to make sure that UK approaches to prevention transforming, and much of the patients receive world-class care at and treatment transformation is being made the cutting edge of what is possible possible by medicines. today and in the future. Recognition Make the best use of data of the role of medicines and new to enhance NHS research The pharmaceutical industry is proud technologies, as well as a commitment capability, generate real world to have been a partner to the NHS to encourage the discovery of evidence and allow the value throughout its 70-year history. The innovative medicines and their use in of innovation to be more industry’s collaboration with the UK the UK, would be transformational fully understood Government in producing the Life for patients, the NHS and our Science Industrial Strategy has set the economy. This must be our goal.” right tone of partnership and agenda The current ABPI President, Erik setting. Now, as we look to the health This special edition of the ABPI Cymru Nordkamp (Pfizer UK), reiterated challenges of the future, our industry Wales Bulletin brings together some the importance of collaboration – must play an integral role in long- of the projects we’ve covered over making it the focus of his presidency; term planning for the NHS. the last few years; this is just the tip helping to transform patient care of the iceberg – and our members through improving access to new “Our dedicated scientists and are working across Wales in many medicines and vaccines and ensuring academics can contribute solutions therapy areas. that Britain holds on to its status as and demonstrate how new a world leader in global medicines technologies and medicines can discovery now and post-Brexit. improve patient outcomes, transform Page one ABPI Cymru Wales Bulletin WINTER 2019 Edition 23 Metastatic Breast Cancer (MBC) – Velindre NHS University Trust and Novartis Working Together (first published Summer 2018) The Velindre Cancer Centre provides services to over 1.5 million people across South East Wales and beyond. Each year the cancer centre treats over 5,000 new referrals and around 50,000 new outpatients.1 The first year of the project has seen the achievement of the following outcomes: ◗ Improvement of the clinical • A reduction has been journey for oral SACT patients: demonstrated in overall patient • Trust-agreed Non Medical waiting times from arrival at Prescriber (NMP) Oral SACT hospital to departure with oral Guidelines have been SACT medication. Data shows Members of Velindre NHS University an average of 1hr 18 mins Trust and Novartis; Working Together implemented into the dedicated oral SACT clinics within the NMP-led clinic compared to 2hrs 19 mins Metastatic Breast Cancer (MBC) • A database has been within the consultant-led clinic. created that will capture: patient numbers are increasing along ◗ Improvement of MBC patient care: with the number of treatment options.2 – the number of oral SACT To ensure treatment optimisation the patients seen in clinic • Establishment and delivery of an MBC patients require holistic support. per week oral SACT dedicated outpatient This can be provided through different clinic for patients initiated onto – the percentage of oral models of care depending on their an oral SACT and a dedicated SACT patients accessed needs with a key patient support telephone service for patients in the new pharmacy-led clinic worker such as a Non Medical have been put in place. Prescriber (NMP) pharmacist. – the number of patients • All patients on oral SACT receive who have received an education on treatment and how The Velindre Cancer Centre MBC education review service did not have the level of to manage toxicities, and toxicity resource required to support a service – the number of patients who assessments as required. development that would ensure received a toxicity assessment • Patient survey shows patients receive this holistic support – the number of patients improvement in patient and achieve treatment optimisation. where a prescriber has been experience, adherence This identified unmet need led to contacted to clarify any issues. and concordance. the development, and implementation, of the two-year joint working project (JWP) between Novartis and In addition to these successful funding; utilising the evidence Velindre NHS University Trust to outcomes, the MBC project team created throughout the project, develop the Metastatic Breast shared learnings with the Royal and ensuring a sustainable service Cancer (MBC) Service. United Bath oral SACT clinic, the NHS continues at the end of this JWP. Grampian Melanoma oral SACT clinic The JWP started in December 2016 and the NMP forum with the British • Velindre Team: Ms Bethan with clear aims and objectives that Oncology Pharmacy Association Tranter, Chief Pharmacist; sought to ensure treatment (BOPA). The MBC project team have Dr Annabel Borley, Consultant optimisation for MBC patients within also been successful in submitting Oncologist and Clinical Lead; the Trust by improving patient care a poster on the year 1 outcomes to Ms Sophie Harding, Lead through stratification of patients into the International Pharmaceutical Pharmacist; Ms Sarah Gorman, different models of care dependent Federation (FIP) World Congress in Senior Pharmacy Technician on their needs, increasing MBC September 2018 in Glasgow and patient concordance and adherence were recently shortlisted for the 2018 to therapy through additional support, • Novartis Team: Maggie Clark, Welsh Pharmacy of the Year awards. establishing oral Systemic Anti- Government Affairs & Access Cancer Treatment (SACT) dedicated The first-year outcomes of this JWP Manager; Sarah Rawcliffe, clinics and improving treatment have demonstrated the value of this Disease Area Specialist; John pathways for oral SACT MBC patients service development and with the Bowen, Disease Area Specialist; across South East Wales by adhering project moving into its second year, Vivek Basantani, Customer to local guidelines and links into the a key outcome will be to create the Relationships Team leader multi-disciplinary team meetings. business case for sustainable 1 www.velindrecc.wales.nhs.uk/about-us 2 www.velindrecc.wales.nhs.uk/sitesplus/documents/1087/Velindre%20Cancer%20Centre%20Annual%20Report%202014.pdf (page 9) Page two ABPI Cymru Wales Bulletin WINTER 2019 Edition 23 The role of medicines in a Prudent NHS The conference also acknowledged that one of the challenges facing the NHS is to improve patient compliance with their medicines. One route to address this would be to work with patients and carers to improve their understanding of their medicines and the How Wales is getting importance of adherence, thereby encouraging self- management and avoiding it right with Prudent medicines wastage and unplanned hospital admissions. (first published Spring 2017) Healthcare Decision-making processes about the availability of medicines In autumn 2016, AbbVie worked with the Bevan Commission should look beyond the cost of to bring together the public, patients, policymakers and acquisition and allow greater healthcare professionals in Cardiff to discuss how the consideration of the value that Prudent Healthcare Principles were being put into practice. medicines can bring to the wider health and social care system. The day-long conference followed unnecessary and unplanned Going forward, translating the Bevan’s maxim of “from cradle to hospital care episodes. Services rhetoric of Prudent Healthcare grave” and looked at how Prudent and care pathways need to be into reality will require some Healthcare is being rolled out across designed to provide support clear actions, and suggestions age groups: older years, working around the patient as close to for further actions include: age, teenagers and young people, home as possible. Introducing educational and early years. Patient engagement, in decisions programmes for young people While the issues discussed as part around their own care and also to inform them of how best to of the four panel discussions varied, involvement in decisions about make use of the health service depending on life stage, three clear how services are shaped and and encourage them to make themes emerged: delivered, is a sentiment expressed healthy choices; at all life stages. Patients need Early intervention, particularly Reviewing